KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Return on Equity (2016 - 2025)

Resmed's Return on Equity history spans 16 years, with the latest figure at 0.24% for Q4 2025.

  • For Q4 2025, Return on Equity changed 0.0% year-over-year to 0.24%; the TTM value through Dec 2025 reached 0.24%, changed 0.0%, while the annual FY2025 figure was 0.26%, 3.0% up from the prior year.
  • Return on Equity reached 0.24% in Q4 2025 per RMD's latest filing, roughly flat from 0.24% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.24% in Q2 2025 to a low of 0.16% in Q1 2021.
  • Average Return on Equity over 5 years is 0.22%, with a median of 0.22% recorded in 2023.
  • Peak YoY movement for Return on Equity: fell -9bps in 2021, then rose 8bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 0.17% in 2021, then surged by 33bps to 0.23% in 2022, then decreased by -10bps to 0.2% in 2023, then rose by 17bps to 0.24% in 2024, then fell by 0bps to 0.24% in 2025.
  • Per Business Quant, the three most recent readings for RMD's Return on Equity are 0.24% (Q4 2025), 0.24% (Q3 2025), and 0.24% (Q2 2025).